| Page | |
| EDITORIALS |
| 300 | Recommendations from the Medical Education Editor
|
| 303 | Obesity is a major contributing cause of breathlessness in the population
|
| 305 | Two steps forward following an acute exacerbation of COPD
Annemarie L Lee BPhysio, MPhysio(CardioPhysio), PhD, Sonia Cheng BAppSc(Physio), PhD, Zoe J McKeough BAppSc(Physio), PhD
10.1111/resp.14415
See related article |
| 307 | Standardized exposure reporting in hypersensitivity pneumonitis: Making a silk purse from a sow's ear
|
| COMMENTARIES |
| 309 | The tobacco endgame for the Asia-Pacific
Henry M Marshall FRACP, PhD, Coral E Gartner PhD, Kwun M Fong FRACP, PhD
10.1111/resp.14465 |
| 313 | Air pollution and lung cancer—A new era
Edward K H Stephens BBSc Hons, Henry M Marshall FRACP, PhD, Venessa Chin FRACP, PhD, Kwun M Fong FRACP, PhD
10.1111/resp.14464 |
| CLINICAL PRACTICE GUIDELINE |
| 316 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Alvar Agustí, Bartolome R Celli, Gerard J Criner, David Halpin, Antonio Anzueto, Peter Barnes, Jean Bourbeau, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca, Kevin Mortimer, Alberto Papi, Ian Pavord, Nicolas Roche, Sundeep Salvi, Don D Sin, Dave Singh, Robert Stockley, M Victorina López Varela, Jadwiga A Wedzicha, Claus F Vogelmeier
10.1111/resp.14486 |
| POSITION PAPER |
| 339 | Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand
Anne B Chang, Scott C Bell, Catherine A Byrnes, Paul Dawkins, Anne E Holland, Emma Kennedy, Paul T King, Pamela Laird, Sarah Mooney, Lucy Morgan, Marianne Parsons, Betty Poot, Maree Toombs, Paul J Torzillo, Keith Grimwood
10.1111/resp.14479 |
| ORIGINAL ARTICLES |
| Asthma and Allergy |
| 350 |
Contribution of obesity to breathlessness in a large nationally representative sample of Australian adults
Yue Leon Guo, Maria R Ampon, Leanne M Poulos, Sharon R Davis, Brett G Toelle, Guy B Marks, Helen K Reddel
10.1111/resp.14400
Obesity is related to breathlessness symptoms. However, the contribution of obesity to breathlessness has not been clearly documented. Our study found that one-quarter of breathlessness symptoms in Australian adults was attributable to obesity. This remained the case after adjusting for common medical conditions known to be associated with breathlessness.
See related Editorial |
| COPD |
| 357 | Promotion of physical activity after hospitalization for COPD exacerbation: A randomized control trial
Beatriz Valeiro, Esther Rodríguez, Paula Pérez, Alba Gómez, Ana Isabel Mayer, Alejandro Pasarín, Jordi Ibañez, Jaume Ferrer, Maria Antonia Ramon
10.1111/resp.14394
We assessed the efficacy of a physical activity program after hospitalization for a COPD exacerbation. The participants of a 12-week patient-tailored, pedometer-based, progressive and target-driven physical activity program, increased their daily steps compared to control group after discharge.
See related Editorial |
| Environmental and Occupational Lung Disease |
| 366 | Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire
Hayley Barnes, Daniel Chambers, Chris Grainge, Tamera J Corte, Shalini Bastiampillai, Simon Frenkel, Glen Westall, Harold Collard, Ian Glaspole
10.1111/resp.14404
This case–control study found that a standardized evidence-based chronic hypersensitivity pneumonitis (CHP) exposure questionnaire increased the diagnostic confidence of CHP and reduced the proportion of antigen-indeterminate CHP.
See related Editorial |
| Interstitial Lung Disease |
| 373 | Immunomodulatory treatment in unclassifiable interstitial lung disease: A retrospective study of treatment response
Charlotte Hyldgaard, Sebastiano Torrisi, Sissel Kronborg Brix-White, Thomas Skovhus Prior, Claudia Ganter, Elisabeth Bendstrup, Michael Kreuter
10.1111/resp.14409
Patients with unclassifiable interstitial lung disease who received immunomodulatory therapy had similar pulmonary function trajectories as patients who did not receive therapy despite more severe disease at baseline in treated patients. This suggests a lack of overall improvement, although immunomodulatory therapy may have effect in a subgroup of patients.
|
| 380 | Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis
Hiroki Tanahashi, Kakuhiro Yamaguchi, Koji Kurose, Satoshi Nakao, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Toru Oga, Mikio Oka, Noboru Hattori
10.1111/resp.14425
CIP incidence in the patients with high levels of serum HMGB1 (≥ 11.24 ng/ml) was significantly and reproducibly higher than in those with its low levels (<11.24 ng/ml) in patients with NSCLC. Our results suggest that HMGB1 may be a potential blood marker for the prediction of CIP.
|
| Interventional Pulmonology |
| 389 | Virtual bronchoscopic navigation and endobronchial ultrasound with a guide sheath without fluoroscopy for diagnosing peripheral pulmonary lesions with a bronchus leading to or adjacent to the lesion: A randomized non-inferiority trial
Xiaoxuan Zheng, Changhao Zhong, Fangfang Xie, Shiyue Li, Guiqi Wang, Lei Zhang, Jiayuan Sun
10.1111/resp.14405
The randomized multicenter clinical trial evaluated that transbronchial diagnosis of PPLs suspicious of malignancy and presence of a bronchus leading to or adjacent to lesions using VBN-rEBUS-GS without fluoroscopy was a safe and effective method and it was non-inferior to VBN-rEBUS-GS with fluoroscopy.
|
| FORUM AND DEBATE |
| Personal Reflections |
| 399 | Language concordance in healthcare: Beyond just talk
|
| 401 | Home sweet home... or is it?
|
| 403 | Omics technologies to study virus infection and chronic lung diseases
|
| Letter from Asia-Pacific and Beyond |
| 404 | Letter from Iceland
|
| 406 | Lessons from a failed randomized controlled trial of speech pathology intervention in vocal cord dysfunction
Joo Koh, Debra Phyland, Laurence Ruane, Adriana Avram, Elizabeth Leahy, Kenneth K Lau, Martin MacDonald, Paul Leong, Malcolm Baxter, Philip G Bardin
10.1111/resp.14477 |
| 409 | Promotion of physical activity after hospitalization for COPD exacerbation: Aids and barriers
|
| 411 | Reply: Promotion of physical activity after hospitalization for COPD exacerbation: The importance of the motivational interview
|
| 412 | A response to the study by Hyldgaard et al.
|
| 414 | Reply: A response to the study by Hyldgaard et al.
|
